Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; (NASDAQ:
$CRON), (NASDAQ: $NEPT), (CSE: $HUGE.C), (TSXV: $KHRN.V), (CSE: $CHOO.C)
Pt. Roberts, WA; Delta, BC –June 19, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of
its new series, Investorideas.com potcastsCM - cannabis news and stocks to
watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/06197Potcasts-NASDAQCRONNEPTCSEHUGECHOOTSXKHRN.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast ;
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts. Today’s podcast features news from Cronos Group
Inc. (NASDAQ:
CRON and TSX:
CRON) , Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT and TSX: NEPT) , FSD Pharma Inc ( CSE:HUGE) , Khiron Life Sciences Corp. (TSXV: KHRN ) and Choom™ ( CSE:
CHOO and OTCQB:
CHOOF).
Cronos Group
Inc. announced that Cronos Australia Pty Ltd. has been granted a medicinal
cannabis Manufacture License by the Australian Office of Drug Control. This
license permits manufacturing of cannabinoid based products in Australia and is
required for all forms of extraction, refining, concentration and
transformation of the cannabis plant.
"We are
thrilled that Cronos Australia was granted the Manufacture License, circling
out the licenses for domestic production which include the medicinal cannabis
Cultivation License and Research License," said Mike Gorenstein, CEO of
Cronos Group. "This is a key step for expanding our research and product
development while also allowing us to produce the full scope of cannabis
products for the region."
Neptune
Technologies & Bioressources Inc. today announced that it entered into a
multi-year agreement with Canopy Growth. Under the terms of the agreement,
Neptune will supplement Canopy Growth's extraction, refinement, and extract
product formulation capacity.
"We are
truly excited to partner with such a great company as Canopy Growth. This
multi-year agreement, including minimum volume commitments, will be supported
by Neptune's decades of experience in extraction, purification and formulation
of value added differentiated science-based products," said Michel
Timperio, President of Neptune's Cannabis Business.
FSD Pharma
Inc. announced the signing of a partnership agreement between FV Pharma Inc., a
wholly-owned subsidiary of the Company, and Cannara Biotech Inc. effective May
31, 2018. The agreement creates the ability for the Company to become the largest
indoor medical cannabis growing operation in North America. Together, FV Pharma
and Cannara have a combined floor space of over 1.245 million square feet of
indoor growing capacity.
Khiron Life
Sciences Corp., a Canadian integrated medical cannabis company with its core
operations in Colombia, announced today that its newly appointed Vice President
of Compliance, Matt Murphy, appeared on CBS Network's June 17, 2018 airing of 60 Minutes to discuss important
aspects of the U.S. opioid crisis. Murphy, a former Chief of Pharmaceutical
Investigations for the DEA, is an internationally recognized security
expert with broad-based domestic and international expertise in the fields of
drug law enforcement, risk assessment and system development, regulatory
compliance, and training.
Murphy and
other senior U.S. Drug Enforcement Administration (DEA) agents revealed in the
program detailed investigative accounts that expose a failure by the U.S.
pharmaceutical industry to regulate itself and stem the massive flow of
opioid-based painkillers into the consumer marketplace.
In response
to the problems highlighted in the CBS program Mr. Murphy stated, " Opioid
abuse is one of the greatest preventable global crisis of our times. Yet
research has found that the use of opioids and the associated morbidity and
mortality among vulnerable populations can be drastically reduced through
properly managed and controlled medical cannabis programs."
Choom™, an
emerging, fully-integrated cannabis company, announced that it has advanced the
build-out of its cannabis retail store network in Alberta and British Columbia.
Choom™ has
secured the rights to an additional 7 retail locations in Alberta. Choom has 25
leases in highly strategic and secure locations in Alberta with 24 applications
submitted. Choom has also secured 3 additional B.C. retail leases, combined
with the existing 7, for a total of 10 retail opportunities in B.C. In all
cases, the retail opportunities are subject to all necessary governmental and
municipal approvals being granted. This number is expected to grow over the
coming months as the Company is currently negotiating additional leases with
the intention of submitting applications for retail licenses.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment